Latest Governance Changes News

Page 3 of 13
Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.
Ada Torres
Ada Torres
27 July 2026
Dr Andrew Forrest's investment vehicle has acquired a significant 16.8% stake in EQ Resources from Oaktree, marking a shift from financial to strategic ownership in the leading western tungsten producer.
Maxwell Dee
Maxwell Dee
20 July 2026
Cobre Limited’s Chilean subsidiary has increased its stake in the Sierra Atacama Copper Project from 45% to over 54% through a $12 million capital raise, with a clear path to majority control by year-end.
Maxwell Dee
Maxwell Dee
7 July 2026
Australian Mines (ASX: AUZ) has expanded its exploration footprint at the Boa Vista Gold Project in Brazil, uncovering 14 additional prospective gold targets beyond its flagship VG1 prospect. Four priority targets are advancing toward drill readiness as the company aims to evolve Boa Vista into a district-scale opportunity.
Maxwell Dee
Maxwell Dee
6 July 2026
Salt Listed Funds released its 2026 annual report highlighting governance changes, investment policy updates including Treasury Units and Carbon-Related Businesses, and a notable decline in the Carbon Fund’s unit price over the year.
Claire Turing
Claire Turing
30 June 2026
Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.
Ada Torres
Ada Torres
30 June 2026
IRIS Metals posted a $22.3 million loss for FY26, driven by major impairments on exploration assets and elevated share-based payments. The company pivots away from Edison and Tin Mountain projects, focusing on lithium-rubidium in South Dakota and tungsten in Montana.
Maxwell Dee
Maxwell Dee
29 June 2026
Booster Innovation Fund reported a $1.593 million profit for the year ended March 2026, supported by increased net assets. However, valuation risks persist due to early-stage investments and recent capital raises at lower prices.
Victor Sage
Victor Sage
29 June 2026
New Talisman Gold Mines commissioned its processing plant and secured commercial offtakes while reporting a $2.26 million net loss in FY26. The company is refocusing on geological modelling and targeted drilling to boost resource confidence and production.
Maxwell Dee
Maxwell Dee
29 June 2026
Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.
Ada Torres
Ada Torres
26 June 2026
EROAD Limited reported stable FY26 revenue of NZD 195 million amid a $134.7 million North American impairment, unveiling a strategic reset centred on ANZ growth and its expanding electronic Road User Charges platform.
Sophie Babbage
Sophie Babbage
24 June 2026
SkyCity Entertainment Group and its Adelaide arm have struck a non-binding deal with South Australian regulators to settle long-running compliance issues, including a A$21 million fine and major governance changes at the Adelaide Casino.
Victor Sage
Victor Sage
19 June 2026

Browse the archive

Full archive